Warren, NJ, March 26, 2015 –(PR.com)– NJ-based Prosidyan™ (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it has received FDA 510(k) clearance of FIBERGRAFT™ BG Putty – Bone Graft Substitute. This is the second generation product in

Related posts:

  1. BioStructures, LLC Receives 510(k) Clearance for Innovative Bioactive Bone Graft Putty and Bone Graft Extender.
  2. Synergy Biomedical Announces Expanded FDA Clearance of BIOSPHERE PUTTY for Spine Indications
  3. Orthovita Gets FDA Clearance for Vitoss Bioactive Foam-2X Bone Graft Substitute
Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone